Report Highlights
The global market for microbes and microbial products is estimated to increase from $242.0 billion in 2022 to reach $346.3 billion by 2027, at a compound annual growth rate (CAGR) of 7.4% from 2022 through 2027.
Report Includes
- 27 tables
- An overview of the global market and technologies for microbial products with special focus on their applications
- Estimation of the market size and analyses of global market trends, with data from 2019-2021, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the current and future market potential and quantification of microbial products market based on type, application, and region
- Detailed descriptions of probiotics, their types, and recent developments and information on microbial pesticides and biofertilizers and their potential uses
- Analysis of underlying technological, environmental, legal/regulatory, and political trends that may influence the size and nature of the market
- Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies
- Comprehensive company profiles of the leading players of the industry, including Seres Therapeutics, Enterome Biosciences, Ferring Pharmaceutics, Evelo Biosciences, Finch Therapeutics, Microbiome Therapeutics, and Pylum Biosciences
Report Scope
This report addresses the global market for microbes and microbial products used in commercial applications from 2021 through 2027. This includes agricultural, healthcare, manufacturing, energy, and environmental applications.
Viruses are sometimes classified as microbes, but they are nonliving, and thus they are excluded from this report.
Major elements cited in this study include:
- Summary.
- Definitions.
- Description of microbes.
- Microbe end-uses and applications.
- Regulation.
- Recent technological developments.
- Market size and segmentation from 2021 to 2027.
- Company profiles.
- Key patents.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2021 | ||||||||||||||||||||||||||||||||||||||||||||||
| Forecast period considered | 2022-2027 | ||||||||||||||||||||||||||||||||||||||||||||||
| Base year market size | $229.9 billion | ||||||||||||||||||||||||||||||||||||||||||||||
| Market size forecast | $346.3 billion | ||||||||||||||||||||||||||||||||||||||||||||||
| Growth rate | CAGR of 7.4% for the forecast period of 2022-2027 | ||||||||||||||||||||||||||||||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||||||||||||||||||||||||||||||
| Segments covered | Segment, product type, end-use, region | ||||||||||||||||||||||||||||||||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World | ||||||||||||||||||||||||||||||||||||||||||||||
| Countries covered | United States, Canada, Germany, France, U.K., Spain, Italy, Russia, China, India, Japan, South Korea, Australia, and Singapore | ||||||||||||||||||||||||||||||||||||||||||||||
| Companies studied |
|
||||||||||||||||||||||||||||||||||||||||||||||
Frequently Asked Questions (FAQs)
- Novozymes
- Lam International
- Amgen
- Novo Nordisk
- Evolva
- Amyris
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Siemens: 360° Company Analysis (IFT322A)
- Thermo Fisher Scientific Inc.: 360° Company Analysis (HLC309A)
- Needle-Free Devices: Technologies and Global Markets (HLC178C)
- Koninklijke Philips N.V.: 360° Company Analysis (HLC308A)
- Global High Purity Quartz Market (CHM191A)
Related Reports
Human Microbiome-based Drugs and Diagnostics: Global Markets
The global market for human microbiome-based drugs and diagnostics is expected to grow from $393.4 million in 2025 to reach $1.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 25.6% from 2025 through 2030.
Global Microbiome Sequencing Market
The global microbiome sequencing market is expected to grow from $1.5 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.3% during the forecast period of 2024 to 2029.
Intravenous (IV) Therapy and Vein Access: Global Markets
The global market for IV therapy and venous access devices is expected to grow from $57.0 billion in 2024 and is projected to reach $74.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2024 to 2029.
Probiotics in Food, Beverages, Dietary Supplements and Animal Feed
The global market for probiotics is expected to grow from $69.8 billion in 2024 and is projected to reach $102.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.9% during the forecast period of 2024 to 2029.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Global Cell Line and Membrane Market
The global market for cell lines and membranes was valued at $5.7 billion in 2024 and is estimated to increase from $6.3 billion in 2025 to reach $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 12.5% from 2025 through 2030.
Human Microbiome-based Drugs and Diagnostics: Global Markets
The global market for human microbiome-based drugs and diagnostics is expected to grow from $393.4 million in 2025 to reach $1.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 25.6% from 2025 through 2030.
Global Microbiome Sequencing Market
The global microbiome sequencing market is expected to grow from $1.5 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.3% during the forecast period of 2024 to 2029.
Proteomics: Technologies and Global Markets
The global market for proteomic technologies was valued at $27.6 billion in 2024. It is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030.
Biologic Therapeutic Drugs: Technologies and Global Markets
The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.
Top Trending Reports
Next-Generation Advanced Batteries: Global Markets
The global market for next-generation advanced batteries is estimated to grow from $1.5 billion in 2024 to reach $5.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 28.5% from 2024 through 2029.
Global Pharmaceutical Drugs Industry: Competitive Landscape 2023
This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.
Global Markets and Manufacturing Technologies for Protein Drugs
The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.
Biologic Therapeutic Drugs: Technologies and Global Markets
The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.
Global Markets for Emerging Medical Device Technologies
The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.
Report Highlights
The global microbes and microbial products market should reach $302.4 billion by 2023 from $186.3 billion in 2018 at a compound annual growth rate (CAGR) of 10.2% for the period 2018-2023.
Report Includes
- 29 data tables and 21 additional tables
- An overview of the global market for microbial products, technologies, and applications
- Analyses of global market trends, with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Identifications of microbial applications in a wide range of fields, i.e., agriculture, healthcare, manufacturing, energy, and environment
- Information about microbial pesticides and biofertilizers and their potential uses
- Detailed descriptions of probiotics, their types, and recent developments
- Coverage of microbial fuel cell technologies and their types, i.e., mediator microbial fuel cells, microbial electrolysis cells, soil-based microbial fuel cells, phototropic biofilm microbial fuel cells, and nanoporous membrane microbial fuel cells
- Comprehensive company profiles of major players in the market, including Certis USA LLC, Taiwan Chlorella Manufacturing Co., Amgen Inc., Leadiant, AB Mauri, Genencor, and Amyris Inc.
Report Highlights
The global market for microbes and microbial products was valued at $143.5 billion in 2014. The 2015 market is projected to approach $154.7 billion, and the 2020 market, nearly $306 billion, with a compound annual growth rate (CAGR) of 14.6% from 2015 to 2020.
Report Includes
- An overview of the global market for microbial products, technologies and their applications.
- Analyses of global market trends, with data from 2014, estimates for 2015, and projections of CAGRs through 2020.
- Identifications of microbial applications in a wide range of fields, the applications and end uses that appear to have significant commercial potential in the near to mid-term, and quantitative estimates of their current and/or future sales.
- Examination of market drivers, regulations, and recent technological developments.
- Information gathered from developers, vendors, and users of microbial products for commercial applications.
- Comprehensive company profiles of major players.
Report Highlights
The total global market for microbes and microbial products was worth more than $117 billion in 2012. The 2013 market is projected to approach $134 billion, and, by 2018, $179 billion, with a projected five year compound annual growth rate (CAGR) of 6%.
Report Includes
- An overview of the global market for microbes and microbial products.
- Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Identifications of microbial applications in a wide range of fields, the applications and end uses that appear to have significant commercial potential in the near to mid-term, and quantitative estimates of their current and/or future sales.
- Examination of market drivers, regulations, and recent technological developments.
- Comprehensive company profiles of major players.
Report Highlights
The total global market for microbes and microbial products was worth more than $144 billion in 2010. The 2011 market is projected to exceed $156 billion, and, by 2016, $259 billion, reflecting a 10.7% projected compound annual growth rate (CAGR) between 2011 and 2016.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More